Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Alzheimer's disease: Unique markers for diagnosis & new treatment modalities.
The combination of fludarabine, cyclophosphamide, and granulocyte-macrophage colony-stimulating factor in the treatment of patients with relapsed chronic lymphocytic leukemia and low-grade Non-Hodgkin's lymphoma.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Alzheimer's disease: Unique markers for diagnosis & new treatment modalities.
Alzheimer's disease: Unique markers for diagnosis & new treatment modalities. Indian J Med Res. 2015 Oct; 142(4):369-82.
View in:
PubMed
subject areas
Aged
Alzheimer Disease
Amyloid beta-Peptides
Biomarkers
Cognitive Dysfunction
Dementia
Humans
Middle Aged
Molecular Targeted Therapy
tau Proteins
authors with profiles
David Bennett
Raj Shah
Neelum Aggarwal